AU1791599A - Novel compounds - Google Patents
Novel compounds Download PDFInfo
- Publication number
- AU1791599A AU1791599A AU17915/99A AU1791599A AU1791599A AU 1791599 A AU1791599 A AU 1791599A AU 17915/99 A AU17915/99 A AU 17915/99A AU 1791599 A AU1791599 A AU 1791599A AU 1791599 A AU1791599 A AU 1791599A
- Authority
- AU
- Australia
- Prior art keywords
- pyridyl
- yloxy
- butyl
- dione
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704546A SE9704546D0 (sv) | 1997-12-05 | 1997-12-05 | Novel compounds |
| SE9704546 | 1997-12-05 | ||
| PCT/SE1998/002190 WO1999029686A1 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1791599A true AU1791599A (en) | 1999-06-28 |
Family
ID=20409283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU17915/99A Abandoned AU1791599A (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1037889A1 (pt) |
| JP (1) | JP2001525406A (pt) |
| KR (1) | KR20010032800A (pt) |
| CN (1) | CN1284074A (pt) |
| AU (1) | AU1791599A (pt) |
| BR (1) | BR9813378A (pt) |
| CA (1) | CA2312357A1 (pt) |
| EE (1) | EE200000321A (pt) |
| HU (1) | HUP0100731A3 (pt) |
| IL (1) | IL136368A0 (pt) |
| NO (1) | NO20002787L (pt) |
| PL (1) | PL340837A1 (pt) |
| SE (1) | SE9704546D0 (pt) |
| SK (1) | SK8442000A3 (pt) |
| TR (1) | TR200001544T2 (pt) |
| WO (1) | WO1999029686A1 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901875D0 (sv) * | 1999-05-25 | 1999-05-25 | Astra Pharma Prod | Novel compounds |
| SE9904505D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Pharma Prod | Novel compounds |
| SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| JP2002330787A (ja) * | 2000-10-21 | 2002-11-19 | Astrazeneca Ab | 化学物質 |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
| ATE355273T1 (de) | 2003-05-12 | 2006-03-15 | Pfizer Prod Inc | Benzamidinhibitoren des p2x7-rezeptors |
| GB0324498D0 (en) | 2003-07-21 | 2003-11-26 | Aventis Pharma Inc | Heterocyclic compounds as P2X7 ion channel blockers |
| BRPI0512781A (pt) | 2004-06-29 | 2008-04-08 | Pfizer Prod Inc | método para preparação de derivados de 5-{4-(2-hidroxi-propil)-3,5-dioxo-4,5-diidro-3h-[1,2,4]tria zin-2-il}-benzamida através da desproteção dos precursores de protetores de hidroxila |
| US8546579B2 (en) | 2006-03-16 | 2013-10-01 | Evotec (Us) Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| BRPI0709596A2 (pt) | 2006-03-16 | 2011-07-19 | Renovis Inc | compostos bicicloeteroarila como moduladores de p2x7 e seus usos |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| TW200813018A (en) | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
| KR101398264B1 (ko) * | 2006-07-06 | 2014-05-26 | 글락소 그룹 리미티드 | Ｐ２ｘ７수용체 길항제로서의 치환된 ｎ페닐메틸５옥소프롤린２아미드 및 그의 사용 방법 |
| GB0613473D0 (en) * | 2006-07-06 | 2006-08-16 | Glaxo Group Ltd | Novel compounds |
| EP2124562B1 (en) | 2007-03-09 | 2016-04-20 | Second Genome, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| JP2010522711A (ja) * | 2007-03-28 | 2010-07-08 | グラクソ グループ リミテッド | Ｐ２ｘ７調節因子としてのピペリジノンカルボキサミド誘導体 |
| EP2139875A2 (en) * | 2007-03-29 | 2010-01-06 | Glaxo Group Limited | Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
| EA200970912A1 (ru) | 2007-04-03 | 2010-02-26 | Глэксо Груп Лимитед | Карбоксамидные производные имидазолидина в качестве модуляторов p2x7 |
| US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
| GB0803729D0 (en) * | 2008-02-29 | 2008-04-09 | Ge Healthcare Ltd | Imaging the central nervous system |
| CA2719745C (en) | 2008-03-25 | 2016-07-05 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| ATE541832T1 (de) | 2009-04-14 | 2012-02-15 | Affectis Pharmaceuticals Ag | Neuartige p2x7r-antagonisten und ihre verwendung |
| EP2322149A1 (en) | 2009-11-03 | 2011-05-18 | Universidad del Pais Vasco | Methods and compositions for the treatment of ischemia |
| CN102858741A (zh) | 2010-05-14 | 2013-01-02 | 阿费克蒂斯制药股份公司 | 制备p2x7r拮抗剂的新方法 |
| WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| AU2018372136B2 (en) | 2017-11-21 | 2022-01-27 | Solventum Intellectual Properties Company | Oral plant-based-oil-in-water emulsions and methods of use |
| CN111511348A (zh) | 2017-12-20 | 2020-08-07 | 3M创新有限公司 | 口腔组合物及使用方法 |
| EP3727336A1 (en) | 2017-12-20 | 2020-10-28 | 3M Innovative Properties Company | Oral compositions and methods of use |
-
1997
- 1997-12-05 SE SE9704546A patent/SE9704546D0/xx unknown
-
1998
- 1998-12-01 EP EP98962753A patent/EP1037889A1/en not_active Withdrawn
- 1998-12-01 AU AU17915/99A patent/AU1791599A/en not_active Abandoned
- 1998-12-01 CA CA002312357A patent/CA2312357A1/en not_active Abandoned
- 1998-12-01 CN CN98813490A patent/CN1284074A/zh active Pending
- 1998-12-01 SK SK844-2000A patent/SK8442000A3/sk unknown
- 1998-12-01 BR BR9813378-0A patent/BR9813378A/pt not_active Application Discontinuation
- 1998-12-01 IL IL13636898A patent/IL136368A0/xx unknown
- 1998-12-01 HU HU0100731A patent/HUP0100731A3/hu unknown
- 1998-12-01 EE EEP200000321A patent/EE200000321A/xx unknown
- 1998-12-01 KR KR1020007006117A patent/KR20010032800A/ko not_active Application Discontinuation
- 1998-12-01 JP JP2000524280A patent/JP2001525406A/ja not_active Withdrawn
- 1998-12-01 PL PL98340837A patent/PL340837A1/xx unknown
- 1998-12-01 TR TR2000/01544T patent/TR200001544T2/xx unknown
- 1998-12-01 WO PCT/SE1998/002190 patent/WO1999029686A1/en not_active Application Discontinuation
-
2000
- 2000-05-31 NO NO20002787A patent/NO20002787L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813378A (pt) | 2000-10-10 |
| EP1037889A1 (en) | 2000-09-27 |
| CA2312357A1 (en) | 1999-06-17 |
| EE200000321A (et) | 2001-08-15 |
| HUP0100731A2 (hu) | 2002-05-29 |
| IL136368A0 (en) | 2001-06-14 |
| TR200001544T2 (tr) | 2000-11-21 |
| KR20010032800A (ko) | 2001-04-25 |
| JP2001525406A (ja) | 2001-12-11 |
| SE9704546D0 (sv) | 1997-12-05 |
| PL340837A1 (en) | 2001-02-26 |
| HUP0100731A3 (en) | 2002-08-28 |
| WO1999029686A1 (en) | 1999-06-17 |
| NO20002787D0 (no) | 2000-05-31 |
| NO20002787L (no) | 2000-08-01 |
| CN1284074A (zh) | 2001-02-14 |
| SK8442000A3 (en) | 2001-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1791599A (en) | Novel compounds | |
| EP3661921B1 (en) | Selective inhibitors of nlrp3 inflammasome | |
| AU2006207300B2 (en) | Substituted triazole derivatives as oxytocin antagonists | |
| DE60005560T2 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
| EP1716135B1 (en) | Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists | |
| JP2020530446A (ja) | 化合物、組成物、及び、方法 | |
| US7649002B2 (en) | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists | |
| CN106061976A (zh) | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 | |
| US10167281B2 (en) | Substituted thiazole or oxazole P2X7 receptor antagonists | |
| CA3018346A1 (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists | |
| KR20160090304A (ko) | 우레아 유도체 또는 그의 약리학적으로 허용되는 염 | |
| EP2974730B1 (en) | Drug for respiratory diseases | |
| US11008301B2 (en) | Piperidinone formyl peptide 2 receptor agonists | |
| JP2016523851A (ja) | 新規ｃｙｐ１７阻害剤／抗アンドロゲン | |
| KR20210114972A (ko) | 치환된 피롤리딘 아마이드 iii | |
| JPH07145057A (ja) | 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
| CN109476653B (zh) | 类视黄醇相关孤儿受体γ的杂芳族调节剂 | |
| EP3398941A1 (en) | Heterocyclic p2x7 antagonists | |
| JP2024508687A (ja) | プロテインホスファターゼ２ａ（ｐｐ２ａ）の置換環状調節物質およびこれを用いた方法 | |
| US11168074B2 (en) | Potassium channel inhibitors | |
| US20220259224A1 (en) | Imidazolo derivatives, compositions and methods as orexin antagonists | |
| MXPA00005327A (en) | Novel compounds | |
| TW202115023A (zh) | 新型細胞凋亡訊號調節激酶1抑制劑 | |
| WO2023177593A1 (en) | Phenyl triazole mll1-wdr5 protein-protein interaction inhibitor | |
| NZ786241A (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |